In this free webinar, learn possible strategies for improving the utilization of new early detection and diagnostic methods. Attendees will learn about the historic utilization of currently available screening tools within the healthcare setting. The featured speakers will discuss what impacts the diagnostic process within healthcare from the practicing physician and patient perspective. The speakers will also discuss how strategies for improving the use of new early detection and diagnostic methods can inform clinical trial design and decisions around investigator collaborations in clinical trials.
TORONTO, Oct. 27, 2022 /PRNewswire-PRWeb/ -- The clinical trial pipeline of early detection and diagnostic products is rapidly expanding. Since healthcare can often be better characterized as "sick care," this expansion holds great promise for intersecting with patients earlier in their disease progression to improve outcomes. However, the historic utilization of currently available screening tools indicates significant barriers to the greater adoption of new diagnostic methods and products.
What impacts the diagnostic process within healthcare? How can the lessons learned from these barriers inform clinical trial design to reduce the gap from discovery to utilization and payor coverage?
In this webinar, the featured speakers will explore the barriers between healthcare and new early detection and diagnostic methods and how the strategies used to overcome such challenges can be applied to clinical research, ultimately translating to a more patient-centered trial experience and faster adoption of life-improving and lifesaving tools.
Register for this Elligo Elite Learning Series webinar for expert insights and an engaging discussion on how early detection and diagnostic products will shape the future of healthcare.
Join experts from Elligo Health Research®, Faith Holmes, MD, Medical Director, Senior Vice President of Medical Affairs; and Dawn Sauro, Executive Vice President, Research Strategy, for the live webinar on Monday, November 14, 2022, at 12pm EST (5pm GMT/UK).
For more information, or to register for this event, visit How Early Detection & Diagnostic Products will Shape the Future of Healthcare.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN15943&Transmission_Id=202210270830PR_NEWS_USPR_____UN15943&DateId=20221027)
Share this article